The effect of frailty on quality of life and lower urinary symptoms after robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL study)

The effect of frailty on quality of life and lower urinary symptoms after robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL study) - The effect of frailty on quality of life and lower urinary symptoms after robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040266

Enrollment

200

Registered

2020-05-01

Start date

2017-01-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with prostate cancer treated with robot-assisted radical prostatectomy (RARP)

Exclusion criteria

Exclusion criteria: Patients with prostate cancer treated with radiotherapy or androgen deprivation therapy, and without HRQOL evaluation for 12 months.

Design outcomes

Primary

Measure	Time frame
The effect of frailty on HRQOL between the frail and nonfrail groups from the baseline to 12 months after RARP.	—

Secondary

Measure	Time frame
The effect of frailty on LUTS between the frail and nonfrail groups from the baseline to 12 months after RARP.	—

Countries

Japan

Contacts

Public ContactShingo Hatakeyama

Dept. of Urology, Hirosaki University Graduate School of Medicine Urology

shingorilla2@gmail.com0172395091

Outcome results